MENU
+Compare
BSX
Stock ticker: NYSE
AS OF
Oct 15, 11:16 AM (EDT)
Price
$97.34
Change
+$1.11 (+1.15%)
Capitalization
142.6B

BSX Boston Scientific Corp Forecast, Technical & Fundamental Analysis

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts... Show more

BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BSX with price predictions
Oct 14, 2025

BSX's RSI Indicator climbs out of oversold territory

The RSI Oscillator for BSX moved out of oversold territory on October 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In of the 14 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 48 cases where BSX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BSX just turned positive on October 08, 2025. Looking at past instances where BSX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BSX advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .

BSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BSX as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BSX moved below its 50-day moving average on September 11, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BSX crossed bearishly below the 50-day moving average on September 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BSX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BSX entered a downward trend on October 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.361) is normal, around the industry mean (61.244). P/E Ratio (57.286) is within average values for comparable stocks, (37.499). Projected Growth (PEG Ratio) (1.463) is also within normal values, averaging (1.685). BSX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (7.758) is also within normal values, averaging (79.870).

View a ticker or compare two or three
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BSX is expected to report earnings to fall 4.84% to 71 cents per share on October 22

Boston Scientific Corp BSX Stock Earnings Reports
Q3'25
Est.
$0.71
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.04
The last earnings report on July 23 showed earnings per share of 75 cents, beating the estimate of 73 cents. With 2.56M shares outstanding, the current market capitalization sits at 142.60B.
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
300 Boston Scientific Way
Phone
+1 508 683-4000
Employees
48000
Web
https://www.bostonscientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHCT13.930.37
+2.73%
Community Healthcare Trust
GPCR30.200.01
+0.03%
Structure Therapeutics
CRL170.13-0.51
-0.30%
Charles River Laboratories International
BWBBP19.05-0.07
-0.36%
Bridgewater Bancshares
CUE0.80-0.02
-2.17%
Cue Biopharma

BSX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.36%
ISRG - BSX
71%
Closely correlated
+0.15%
SYK - BSX
65%
Loosely correlated
+1.39%
MMSI - BSX
56%
Loosely correlated
+1.44%
EW - BSX
51%
Loosely correlated
+0.56%
ALC - BSX
49%
Loosely correlated
+2.04%
More

Groups containing BSX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.36%
BSX
(3 stocks)
77%
Closely correlated
+0.30%
Medical/Nursing Services
(220 stocks)
62%
Loosely correlated
+0.04%
Health Services
(430 stocks)
38%
Loosely correlated
+0.06%